Employees Retirement System of Texas lowered its stake in shares of Humana Inc (NYSE:HUM) by 2.7% during the 4th quarter, HoldingsChannel.com reports. The firm owned 43,000 shares of the insurance provider’s stock after selling 1,200 shares during the quarter. Employees Retirement System of Texas’ holdings in Humana were worth $10,667,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Sterling Capital Management LLC bought a new stake in shares of Humana during the second quarter worth about $253,000. Robeco Institutional Asset Management B.V. increased its position in shares of Humana by 5.1% during the third quarter. Robeco Institutional Asset Management B.V. now owns 137,119 shares of the insurance provider’s stock worth $33,403,000 after acquiring an additional 6,694 shares in the last quarter. Oakbrook Investments LLC bought a new stake in shares of Humana during the third quarter worth about $1,523,000. LS Investment Advisors LLC increased its position in shares of Humana by 5.6% during the third quarter. LS Investment Advisors LLC now owns 4,608 shares of the insurance provider’s stock worth $1,123,000 after acquiring an additional 244 shares in the last quarter. Finally, APG Asset Management N.V. increased its position in shares of Humana by 86.6% during the third quarter. APG Asset Management N.V. now owns 455,084 shares of the insurance provider’s stock worth $110,872,000 after acquiring an additional 211,200 shares in the last quarter. Hedge funds and other institutional investors own 97.68% of the company’s stock.
Shares of Humana Inc (NYSE:HUM) opened at $267.33 on Wednesday. Humana Inc has a 52-week low of $203.36 and a 52-week high of $293.35. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.85 and a quick ratio of 1.61. The stock has a market cap of $37,037.08, a PE ratio of 23.01, a price-to-earnings-growth ratio of 1.45 and a beta of 0.93.
The business also recently announced a quarterly dividend, which will be paid on Friday, April 27th. Shareholders of record on Friday, March 30th will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 0.75%. This is a boost from Humana’s previous quarterly dividend of $0.40. The ex-dividend date is Wednesday, March 28th. Humana’s payout ratio is presently 9.59%.
Humana declared that its board has authorized a share buyback plan on Thursday, December 14th that authorizes the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization authorizes the insurance provider to repurchase shares of its stock through open market purchases. Stock repurchase plans are usually an indication that the company’s leadership believes its shares are undervalued.
Several equities research analysts have recently commented on HUM shares. BMO Capital Markets boosted their target price on shares of Humana from $290.00 to $300.00 and gave the stock an “outperform” rating in a research report on Friday, November 10th. Zacks Investment Research downgraded shares of Humana from a “strong-buy” rating to a “hold” rating in a research report on Friday, January 19th. Cowen reissued a “buy” rating and set a $285.00 target price on shares of Humana in a research report on Wednesday, December 13th. Royal Bank of Canada reissued a “sector perform” rating and set a $242.00 target price (down from $245.00) on shares of Humana in a research report on Thursday, November 9th. Finally, Credit Suisse Group decreased their target price on shares of Humana from $256.00 to $246.00 and set a “neutral” rating for the company in a research report on Friday, November 10th. Seven analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of $270.47.
In other Humana news, SVP Jody L. Bilney sold 7,054 shares of the business’s stock in a transaction dated Monday, December 18th. The shares were sold at an average price of $247.89, for a total value of $1,748,616.06. Following the transaction, the senior vice president now directly owns 11,704 shares in the company, valued at $2,901,304.56. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, VP Timothy S. Huval sold 1,382 shares of the business’s stock in a transaction dated Tuesday, December 19th. The shares were sold at an average price of $246.04, for a total transaction of $340,027.28. Following the completion of the transaction, the vice president now owns 11,557 shares in the company, valued at $2,843,484.28. The disclosure for this sale can be found here. Over the last quarter, insiders sold 10,115 shares of company stock worth $2,501,627. Corporate insiders own 0.80% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: This news story was published by BBNS and is the property of of BBNS. If you are viewing this news story on another website, it was illegally copied and republished in violation of U.S. & international copyright & trademark laws. The original version of this news story can be read at https://baseballnewssource.com/markets/employees-retirement-system-of-texas-reduces-stake-in-humana-inc-hum/1898112.html.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.